NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/21/2025
Back to search
Official data from USPTO
SYNETS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
10/22/2025
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
10/04/2024
Registration date
10/21/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
10/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Alexandra NSW, AU
Examiner
GARCIA,CLAUDIA
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "SYNETS". The first letter "S" appears in white and is enclosed by a green rectangle, with a green and white line extending from the rectangle under the letters "YNETS", which are in black.
Holders and representatives
Holders
Biogency Pty Ltd
Representatives
Jennifer A. Visintine Thompson Coburn LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Food supplementsanti-oxidants; capsules sold empty for pharmaceutical purposes; capsules sold empty for veterinary pharmaceutical preparations; chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; collagen based medicated supplements for use as nutritional supplements; decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; antioxidants in the nature of dietary supplements; dietary protein supplements; dietary supplements; dietary supplements for animals; dietary supplements with a cosmetic effect; effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; food supplements for medical purposes to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; herbal dietary supplements; dietary nutritional supplements; nutritional supplements; plant extractsother than essential oilsbeing dietary supplements; medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; pharmaceutical preparations to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations for skin care; pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; chemical products in the nature of chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; natural pharmaceutical products to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical products to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; tablets being pharmaceuticals to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; food supplements for animals in the nature of vitamins; vitamin supplements; dietary food supplements; nutritional drinks being dietary food supplements; food supplements in the nature of dietary supplements
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/02/2025
PUBO
PUBLISHED FOR OPPOSITION
09/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/27/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/27/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/27/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/27/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/10/2025
GNRT
NON-FINAL ACTION E-MAILED
04/10/2025
CNRT
NON-FINAL ACTION WRITTEN
04/10/2025
DOCK
ASSIGNED TO EXAMINER
04/09/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/08/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2025
NWAP
NEW APPLICATION ENTERED
10/04/2024
Continuous trademark protection
Get notified about every new filing that threatens SYNETS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.